Details

Biochemical characteristics of the 6-nitro regioisomer of nitroxoline and its 1,2,3,4-tetrahydroquinoline analogues
ID Mitrović, Ana (Author), ID Knez, Damijan (Author), ID Hrast, Martina (Author), ID Kljun, Jakob (Author), ID Gobec, Stanislav (Author), ID Sosič, Izidor (Author)

.pdfPDF - Presentation file, Download (1,58 MB)
MD5: 0DDF4146853BB8C92AF13FE03860E7ED
URLURL - Source URL, Visit https://acta.pharmaceutica.farmaceut.org/wp-content/uploads/2025/06/23525.pdf This link opens in a new window

Abstract
A significant amount of data about the different pharmacological activities of the established antimicrobial compound nitroxoline (8-hydroxy-5-nitroquinoline) is available in the scientific literature. On the other hand, its regioisomer 8-hydroxy-6-nitroquinoline was never characterised biochemically and the same also applies to their 1,2,3,4-tetrahydroquinoline analogues. Herein, we determined the influence of pyridine ring saturation and the position of the nitro group on various biochemical characteristics of compounds, such as metal-chelating properties, inhibition of methionine aminopeptidases (MetAPs) from Mycobacterium tuberculosis and human MetAP2, as well as antibacterial activities on Escherichia coli, Staphylococcus aureus, and Mycobacterium smegmatis. In addition, inhibition of endopeptidase and exopeptidase activities of cathepsin B was determined, together with the ability of new nitroxoline analogues to reduce intracellular collagen IV degradation. Substantially different biological activities were observed for the 6-nitro regioisomer of nitroxoline, as well as for both of their partially saturated counterparts.

Language:English
Keywords:8-hydroxyquinoline, 1, 2, 3, 4-tetrahydroquinoline, regioisomer, antibacterial activity, cathepsin B, methionine aminopeptidase
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
FKKT - Faculty of Chemistry and Chemical Technology
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:Str. 235-257, 7-9
Numbering:Vol. 75, iss. 2
PID:20.500.12556/RUL-169971 This link opens in a new window
UDC:577.1
ISSN on article:1846-9558
DOI:10.2478/acph-2025-0018 This link opens in a new window
COBISS.SI-ID:240664835 This link opens in a new window
Publication date in RUL:30.06.2025
Views:225
Downloads:53
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Acta pharmaceutica
Shortened title:Acta pharm.
Publisher:Croatian Pharmaceutical Society
ISSN:1846-9558
COBISS.SI-ID:3817585 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:biokemija, 8-hidroksikinolin, 1, 2, 3, 4-tetrahidrokinolin, regioizomer, katepsin B, metionin, aminopeptidaza

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0175
Name:Napredna anorganska kemija

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-0022
Name:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back